Harvard Bioscience Sees Q4 Sales $22.500M-$24.500M vs $23.100M Est
Benzinga Newsdesk 12 months ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $22.500 million-$24.500 million vs $23.100 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $22.500 million-$24.500 million vs $23.100 million analyst estimate.